Mark

Medasense today announced the appointment of Peter Wehrly as Executive Chairman of the Board. Over…

Orikine Bio, a biotechnology company based at the Barcelona Science Park (PCB-UB), today announced the…

READ THIS NEWS IN SPANISH Oriva Therapeutics is launched with the support of Asabys, focused…

Breakthrough device promises significantly improved patient recovery after colorectal surgery SafeHeal®, a leading innovator in…

Interim data from Phase 1 with single and multiple ascending doses show no safety signals…

INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx} company developing graphene-based neural technologies, today announced the…

STENOVA trial achieves primary endpoint in 103 study participants after 12 weeks of treatment Pharmacokinetic…

READ THIS NEWS IN SPANISH The round is led by Quadrille Capital and co-led by…

• Brings over 35 years of oncology drug development experience, including senior executive leadership roles…

READ THIS NEWS IN SPANISH The resulting team will manage over €400M in investments in…